Global /China /Healthcare /Medical Devices /300238

Guanhao Biotech Co.,Ltd.

300238

• SHE: 300238 • Delayed

14.21CNY -1.5%

2.10 USD

As of 14 June 2026, Guanhao Biotech Co.,Ltd. has a market cap of $556.06M USD, ranking #14426 globally and #4461 in China. It ranks #1284 in the Healthcare sector, and #258 in the Medical Devices industry.

Global Rank

14426

Country Rank

4461

Sector Rank

1284

Industry Rank

258

Key Stats

Market Cap

$556.06MUSD

3.77B CNY

Enterprise Value

$539.64MUSD

3.65B CNY

Revenue (TTM)

$57.22MUSD

387.75M CNY

EBITDA (TTM)

$7.54MUSD

51.0M CNY

Net Income (TTM)

$3.59MUSD

24.35M CNY

EBITDA Margin

13%

Profit Margin

6.3%

PE Ratio

157.9

PS Ratio

9.7

PB Ratio

7.7

EV/EBITDA

65.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Feng Zhao open_in_new

Employees

535

Founded

1999

Website

guanhaobio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.5%	-3.4%	-3.7%	-11%	-7.9%	4.2%	16%	14%	-31%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300238 冠昊生物科技股份有限公司 Class A ISIN: CNE100001575 Shares Out.: Shares Outstanding: 265.156M¹ Shares Float: 189.26M² TV: TradingView: SZSE: 300238 SA: Stock Analysis: SHE: 300238 YF: Yahoo Finance: 300238.SZ GF: Google Finance: SHE: 300238 BA: Barron's: 300238 MS: Morningstar: XSHE: 300238	14.21 CNY	TV: TradingView: SZSE: 300238 SA: Stock Analysis: SHE: 300238 YF: Yahoo Finance: 300238.SZ GF: Google Finance: SHE: 300238 BA: Barron's: 300238 MS: Morningstar: XSHE: 300238

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Guanhao Biotech Co.,Ltd.

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 5K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 909%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 893%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 806%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 719%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 31K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 29K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 29K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 23K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 22K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 18K%	22.2	Ireland

chevron_leftBack